Summary

Over 250 branded drugs in the U.S. will see price increases starting Jan. 1, 2025, with most hikes below 10% and a median increase of 4.5%.

Key companies like Pfizer, Bristol Myers Squibb, and Sanofi are raising prices on treatments for COVID-19, cancer, and vaccines, citing R&D costs and inflation.

Some prices, such as Merck’s diabetes drugs, will be reduced.

Critics highlight that U.S. drug prices remain the highest globally, while manufacturers face pressure to moderate year-over-year price hikes.

  • apfelwoiSchoppen@lemmy.world
    link
    fedilink
    arrow-up
    106
    arrow-down
    1
    ·
    edit-2
    5 days ago

    The line must go up. Doesn’t matter that homelessness increased 18% in 2024 in the US. They need that third home and a yacht.

      • Landless2029@lemmy.world
        link
        fedilink
        arrow-up
        38
        ·
        5 days ago

        Its almost like dragons and thier hoards. Just keep piling it up…

        But they’re not magestic like dragons. Still close… Lizard people? Cold blooded. Predatory. It tracks.